scholarly journals TCT-444 Sex-Based Outcomes in Patients Undergoing Watchman Device Implantation

2021 ◽  
Vol 78 (19) ◽  
pp. B182-B183
Author(s):  
Sundeep Kumar ◽  
Ali Ghani ◽  
Hiren Patel ◽  
Ziad SayedAhmad ◽  
Ruthvik Srinivasamurthy ◽  
...  
Keyword(s):  
Device Implantation ◽  
Watchman Device

Left atrial appendage perforation with Watchman device implantation: Strategies for surgical repair

2020 ◽  
Vol 36 (1) ◽  
pp. 398-400 ◽  
Author(s):  
Saqib Masroor ◽  
Qiong Qiu ◽  
Mohamad Alghothani ◽  
Rajesh Gupta ◽  
George V. Moukarbel
Keyword(s):  
Left Atrial ◽  
Left Atrial Appendage ◽  
Surgical Repair ◽  
Atrial Appendage ◽  
Device Implantation ◽  
Watchman Device

scholarly journals Cryoballoon pulmonary vein isolation and voltage mapping for symptomatic atrial fibrillation 9 months after Watchman device implantation

2018 ◽  
Vol 4 (1) ◽  
pp. 6-9 ◽  
Author(s):  
Henry D. Huang ◽  
Viren M. Patel ◽  
Parikshit S. Sharma ◽  
Zenith Jameria ◽  
Sorin Lazar ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Pulmonary Vein ◽  
Pulmonary Vein Isolation ◽  
Device Implantation ◽  
Voltage Mapping ◽  
Watchman Device

Successful WATCHMAN Device Implantation in a Patient with IVC Filter Thrombosis and Iliac Vein Occlusions

2020 ◽  
Vol 21 (3) ◽  
pp. 409-411
Author(s):  
Sercan Okutucu ◽  
Ismail Ates ◽  
Kostas Marmagkiolis ◽  
Gulcan Kose ◽  
Cezar Iliescu ◽  
...  
Keyword(s):  
Iliac Vein ◽  
Ivc Filter ◽  
Device Implantation ◽  
Watchman Device

SAFETY AND EFFICACY OF WATCHMAN DEVICE IMPLANTATION IN PATIENTS WITH VALVULAR HEART DISEASE A MULTICENTER STUDY

2020 ◽  
Vol 75 (11) ◽  
pp. 536
Author(s):  
Amit Shrestha ◽  
Nachiket Apte ◽  
Arslan Naeem ◽  
Seth H. Sheldon ◽  
Matthew Earnest ◽  
...  
Keyword(s):  
Heart Disease ◽  
Multicenter Study ◽  
Valvular Heart Disease ◽  
Safety And Efficacy ◽  
Device Implantation ◽  
Watchman Device

Minimally Invasive Thoracoscopic Exclusion of the Left Atrial Appendage Following Watchman Device With an AtriCure ProV LAA Exclusion Device

2019 ◽  
Vol 14 (6) ◽  
pp. 509-511 ◽  
Author(s):  
Matthew A. Romano
Keyword(s):  
Case Report ◽  
Minimally Invasive ◽  
Left Atrial ◽  
Left Atrial Appendage ◽  
Atrial Appendage ◽  
Residual Flow ◽  
Device Implantation ◽  
Watchman Device

This is a case report of a minimally invasive exclusion of the left atrial appendage with a ProV AtriClip following a Watchman device implantation with residual flow into the left atrial appendage.

scholarly journals Do all patients need intense anticoagulation and antiplatelet regimens following WATCHMAN device implantation? A case series of five patients

2015 ◽  
Vol 24 ◽  
pp. S239
Author(s):  
S. Ramkumar ◽  
M. Tung ◽  
J. Cameron ◽  
B. Pang ◽  
N. Nerlekar ◽  
...  
Keyword(s):  
Case Series ◽  
Device Implantation ◽  
Watchman Device

scholarly journals GENDER DISPARITIES IN OUTCOMES AFTER WATCHMAN DEVICE IMPLANTATION

2021 ◽  
Vol 77 (18) ◽  
pp. 1091
Author(s):  
Purnima Sharma ◽  
Byomesh Tripathi ◽  
Sangeeta Bhat ◽  
Rohi Mishra ◽  
Smit Patel ◽  
...  
Keyword(s):  
Gender Disparities ◽  
Device Implantation ◽  
Watchman Device

scholarly journals Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement

2019 ◽  
Vol 2019 ◽  
pp. 1-3 ◽  
Author(s):  
Tania Ahuja ◽  
Scarlett Murphy ◽  
Daniel J. Sartori
Keyword(s):  
Antithrombotic Therapy ◽  
Left Atrial ◽  
Left Atrial Appendage ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Atrial Appendage ◽  
Left Atrial Appendage Occlusion ◽  
Device Implantation ◽  
Watchman Device ◽  
Device Placement

Antithrombotic therapy for stroke prevention in patients with atrial fibrillation (AF) has dramatically shifted from warfarin, a vitamin K antagonist, to the direct oral anticoagulants (DOACs) such as dabigatran, apixaban, and rivaroxaban. In patients with contraindications to oral anticoagulation, left atrial appendage occlusion (LAAO) devices, such as the Watchman™ device, may be considered; however, temporary postimplantation antithrombotic therapy is still a recommended practice. We present a case of complex antithrombotic management, post LAAO device implantation, designed to avoid drug interactions with concomitant rifampin use and remained necessary secondary to subsequent device leak. This case highlights the challenges of antithrombotic therapy post LAAO device placement in a complex, but representative, patient.

Sign in / Sign up

Export Citation Format

Share Document